- Home
- NSSC vs RCKT Comparison
NSSC vs RCKT Comparison
Compare NSSC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- RCKT
- Stock Information
- Founded
- NSSC 1969
- RCKT 1999
- Country
- NSSC United States
- RCKT United States
- Employees
- NSSC 1070
- RCKT N/A
- Industry
- NSSC Telecommunications Equipment
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- NSSC Telecommunications
- RCKT Health Care
- Exchange
- NSSC Nasdaq
- RCKT Nasdaq
- Market Cap
- NSSC 1.5B
- RCKT 1.9B
- IPO Year
- NSSC N/A
- RCKT N/A
- Fundamental
- Price
- NSSC $39.12
- RCKT $17.13
- Analyst Decision
- NSSC Strong Buy
- RCKT Strong Buy
- Analyst Count
- NSSC 6
- RCKT 9
- Target Price
- NSSC $55.33
- RCKT $53.22
- AVG Volume (30 Days)
- NSSC 350.1K
- RCKT 731.3K
- Earning Date
- NSSC 11-04-2024
- RCKT 11-04-2024
- Dividend Yield
- NSSC 1.27%
- RCKT N/A
- EPS Growth
- NSSC 83.56
- RCKT N/A
- EPS
- NSSC 1.34
- RCKT N/A
- Revenue
- NSSC $188,820,000.00
- RCKT N/A
- Revenue This Year
- NSSC $14.19
- RCKT N/A
- Revenue Next Year
- NSSC $14.67
- RCKT $300.20
- P/E Ratio
- NSSC $29.43
- RCKT N/A
- Revenue Growth
- NSSC 11.07
- RCKT N/A
- 52 Week Low
- NSSC $17.76
- RCKT $15.98
- 52 Week High
- NSSC $58.09
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- NSSC 45.46
- RCKT 46.41
- Support Level
- NSSC $38.53
- RCKT $17.05
- Resistance Level
- NSSC $39.64
- RCKT $17.75
- Average True Range (ATR)
- NSSC 1.11
- RCKT 0.72
- MACD
- NSSC 0.03
- RCKT 0.06
- Stochastic Oscillator
- NSSC 35.31
- RCKT 40.23
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.